Literature DB >> 11893608

Unloading arterial baroreceptors causes neurogenic hypertension.

Terry N Thrasher1.   

Abstract

We developed a new model to examine the role of arterial baroreceptors in the long-term control of mean arterial pressure (MAP) in dogs. Baroreceptors in the aortic arch and one carotid sinus were denervated, and catheters were implanted in the descending aorta and common carotid arteries. MAP and carotid sinus pressure (CSP) averaged 104 +/- 2 and 102 +/- 2 mmHg (means +/- 1 SE), respectively, during a 5-day control period. Baroreceptor unloading was induced by ligation of the common carotid artery proximal to the innervated sinus (n = 6 dogs). MAP and CSP averaged 127 +/- 7 and 100 +/- 3 mmHg, respectively, during the 7-day period of baroreceptor unloading. MAP was significantly elevated (P < 0.01) compared to control, but CSP was unchanged. Heart rate and plasma renin activity increased significantly in response to baroreceptor unloading. Removal of the ligature to restore normal flow through the carotid resulted in normalization of all variables. Ligation of the carotid below a denervated sinus (n = 4) caused a significant decrease in CSP but no systemic hypertension. These results indicate that chronic unloading of carotid baroreceptors can produce neurogenic hypertension and provide strong evidence that arterial baroreceptors are involved in the long-term control of blood pressure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893608     DOI: 10.1152/ajpregu.00431.2001

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  30 in total

1.  Anger in brain and body: the neural and physiological perturbation of decision-making by emotion.

Authors:  Sarah N Garfinkel; Emma Zorab; Nakulan Navaratnam; Miriam Engels; Núria Mallorquí-Bagué; Ludovico Minati; Nicholas G Dowell; Jos F Brosschot; Julian F Thayer; Hugo D Critchley
Journal:  Soc Cogn Affect Neurosci       Date:  2015-08-07       Impact factor: 3.436

2.  Nonlinear identification of the total baroreflex arc.

Authors:  Mohsen Moslehpour; Toru Kawada; Kenji Sunagawa; Masaru Sugimachi; Ramakrishna Mukkamala
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-09-09       Impact factor: 3.619

3.  Sympathetic genes, baroreflexes, and hypertension.

Authors:  Jens Jordan
Journal:  Clin Auton Res       Date:  2004-12       Impact factor: 4.435

Review 4.  Carotid baroreflex testing using the neck collar device.

Authors:  Victoria L Cooper; Roger Hainsworth
Journal:  Clin Auton Res       Date:  2009-02-19       Impact factor: 4.435

5.  [Pathophysiology of hypertension : What are our current concepts?].

Authors:  J Jordan
Journal:  Internist (Berl)       Date:  2015-03       Impact factor: 0.743

Review 6.  Electrical carotid sinus stimulation: chances and challenges in the management of treatment resistant arterial hypertension.

Authors:  Kristine Chobanyan-Jürgens; Jens Jordan
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

Review 7.  Carotid baroreflex activation therapy for resistant hypertension.

Authors:  Ronald G Victor
Journal:  Nat Rev Cardiol       Date:  2015-07-07       Impact factor: 32.419

8.  Computational model-based assessment of baroreflex function from response to Valsalva maneuver.

Authors:  Samuel A Kosinski; Brian E Carlson; Scott L Hummel; Robert D Brook; Daniel A Beard
Journal:  J Appl Physiol (1985)       Date:  2018-09-20

9.  GABAB receptor gene transfer into the nucleus tractus solitarii induces chronic blood pressure elevation in normotensive rats.

Authors:  Bo Li; Qing Liu; Chengluan Xuan; Lirong Guo; Ruofan Shi; Qi Zhang; Stephen T O'Rourke; Kexiang Liu; Chengwen Sun
Journal:  Circ J       Date:  2013-06-25       Impact factor: 2.993

Review 10.  Baroreflex contribution to blood pressure and heart rate oscillations: time scales, time-variant characteristics and nonlinearities.

Authors:  M Di Rienzo; G Parati; A Radaelli; P Castiglioni
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2009-04-13       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.